| |
WABRI is a Curtin University Institute
operating through Curtin's legal authority and
its policies and procedures.
WABRI can therefore enter into relationships with
industry and academic partners through Curtin's
consultancy process and collaborative R&D
arrangements.
Staff at WABRI have extensive experience in these
areas ensuring rapid contracting processes with
clients.
WABRI has had numerous consultancy and R&D
arrangements with clients and partners in the
biotechnology industry.
There are a number of areas where we are actively
seeking business and consultancy opportunities:
- BIOMOLECULAR MODELLING - From drug discovery
to nanotechnology.
- ENDOCRINE MIMETICS - An opportunity for novel
oral diabetes and cancer drug development.
- GAGs - A drug development program targeting
allergic inflammatory diseases, particularly
allergic rhinitis, asthma and eczema.
- GSK3ß - Small molecule drug leads for
type II diabetes, Alzheimer's disease and stroke.
- RAGE PROJECT - An opportunity for novel anti-inflammatory
drug development.
- RAPID DRUG DISCOVERY - The fast way in drug
discovery.
- TFPI-ANTIPHOSPHOLIPID SYNDROME - An opportunity
for diagnostic kit development.
|
|
